학술논문

Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis: Preliminary Results
Document Type
Journal
Source
ANNALS OF NEUROLOGY; SEP 2021, 90 pS98-pS98, 1p. Supplement: 26
Subject
Language
English
ISSN
15318249